299 related articles for article (PubMed ID: 22406297)
21. TNFα-mediated loss of β-catenin/E-cadherin association and subsequent increase in cell migration is partially restored by NKX3.1 expression in prostate cells.
Debelec-Butuner B; Alapinar C; Ertunc N; Gonen-Korkmaz C; Yörükoğlu K; Korkmaz KS
PLoS One; 2014; 9(10):e109868. PubMed ID: 25360740
[TBL] [Abstract][Full Text] [Related]
22. Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.
Tsui KH; Chang YL; Feng TH; Chang PL; Juang HH
Prostate; 2012 Sep; 72(13):1431-42. PubMed ID: 22290289
[TBL] [Abstract][Full Text] [Related]
23. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
Wang M; Hu Y; Amatangelo MD; Stearns ME
Mol Cancer Res; 2011 Jan; 9(1):36-50. PubMed ID: 21148031
[TBL] [Abstract][Full Text] [Related]
24. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells.
Jin SH; Akiyama Y; Fukamachi H; Yanagihara K; Akashi T; Yuasa Y
Int J Cancer; 2008 Mar; 122(5):1040-6. PubMed ID: 17957782
[TBL] [Abstract][Full Text] [Related]
25. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
26. Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin.
Zhou Q; Yan B; Hu X; Li XB; Zhang J; Fang J
Mol Cancer Ther; 2009 Jun; 8(6):1684-91. PubMed ID: 19509250
[TBL] [Abstract][Full Text] [Related]
27. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
28. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
[TBL] [Abstract][Full Text] [Related]
29. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.
Tripathi V; Popescu NC; Zimonjic DB
Oncogene; 2014 Feb; 33(6):724-33. PubMed ID: 23376848
[TBL] [Abstract][Full Text] [Related]
30. STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer.
Wang L; Jin Y; Arnoldussen YJ; Jonson I; Qu S; Maelandsmo GM; Kristian A; Risberg B; Waehre H; Danielsen HE; Saatcioglu F
Cancer Res; 2010 Jul; 70(14):5818-28. PubMed ID: 20587517
[TBL] [Abstract][Full Text] [Related]
31. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs.
Ashida S; Nakagawa H; Katagiri T; Furihata M; Iiizumi M; Anazawa Y; Tsunoda T; Takata R; Kasahara K; Miki T; Fujioka T; Shuin T; Nakamura Y
Cancer Res; 2004 Sep; 64(17):5963-72. PubMed ID: 15342375
[TBL] [Abstract][Full Text] [Related]
32. Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN.
Sharma P; Knowell AE; Chinaranagari S; Komaragiri S; Nagappan P; Patel D; Havrda MC; Chaudhary J
Mol Cancer; 2013 Jun; 12():67. PubMed ID: 23786676
[TBL] [Abstract][Full Text] [Related]
33. Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression.
Fan C; He L; Kapoor A; Gillis A; Rybak AP; Cutz JC; Tang D
Biochim Biophys Acta; 2008 Nov; 1782(11):642-8. PubMed ID: 18817867
[TBL] [Abstract][Full Text] [Related]
34. The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.
Olson A; Le V; Aldahl J; Yu EJ; Hooker E; He Y; Lee DH; Kim WK; Cardiff RD; Geradts J; Sun Z
PLoS Genet; 2019 Oct; 15(10):e1008451. PubMed ID: 31658259
[TBL] [Abstract][Full Text] [Related]
35. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
36. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
[TBL] [Abstract][Full Text] [Related]
37. ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21.
Cosi I; Pellecchia A; De Lorenzo E; Torre E; Sica M; Nesi G; Notaro R; De Angioletti M
J Hematol Oncol; 2020 Aug; 13(1):112. PubMed ID: 32791988
[TBL] [Abstract][Full Text] [Related]
38. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
[TBL] [Abstract][Full Text] [Related]
39. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway.
Ni J; Wen X; Yao J; Chang HC; Yin Y; Zhang M; Xie S; Chen M; Simons B; Chang P; di Sant'Agnese A; Messing EM; Yeh S
Cancer Res; 2005 Nov; 65(21):9807-16. PubMed ID: 16267002
[TBL] [Abstract][Full Text] [Related]
40. N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells.
Nalla AK; Estes N; Patel J; Rao JS
Exp Cell Res; 2011 Oct; 317(17):2512-21. PubMed ID: 21855541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
